![conference banner](/images/conference-banner.jpeg)
Abstract
Background: Polypharmacology means drugs having interactions with multiple targets of a unique disease or many disease pathways. This concept has been greatly appreciated against complex diseases, such as oncology, CNS disorders, and anti-infectives.
Methods: The integration of diverse compounds available on public databases initiates polypharmacological drug discovery research. Immunocompromised patients may suffer from complex diseases. Multiple-component drug formulations may produce side effects and resistance issues due to unintended drug-target interactions.
Results: Polypharmacology remains a novel avenue to propose a more effective and less toxic treatment. The 4-amino quinoline scaffold has become an important construction motif for the development of new drugs against lifestyle diseases like cancer and infectious diseases like tuberculosis and malaria.
Conclusion: The present study is an attempt to explore the polypharmacological effects of 4- aminoquinoline drugs to combat malaria, cancer, and tuberculosis.
Keywords: Multi-target, Polypharmacology, 4-aminoquinolines, Cancer, Malaria, Tuberculosis.
[http://dx.doi.org/10.1586/ecp.12.74] [PMID: 23272792]
[http://dx.doi.org/10.1016/j.molliq.2016.04.074]
[http://dx.doi.org/10.1007/3-540-29088-5_3] [PMID: 16265887]
[http://dx.doi.org/10.1016/S0140-6736(01)05557-X] [PMID: 11502317]
[http://dx.doi.org/10.1128/AAC.00100-12] [PMID: 22508305]
[http://dx.doi.org/10.1002/jps.2600520621]
[PMID: 5876186]
[http://dx.doi.org/10.1128/AAC.00675-10] [PMID: 21383099]
[http://dx.doi.org/10.1186/s40064-015-1593-3] [PMID: 29021931]
[http://dx.doi.org/10.1021/jm020858u] [PMID: 12139464]
[http://dx.doi.org/10.1016/j.ijpddr.2017.10.005] [PMID: 29128848]
[http://dx.doi.org/10.1038/s41598-017-16154-2] [PMID: 29162859]
[http://dx.doi.org/10.1016/S1473-3099(15)00079-1] [PMID: 26342427]
[http://dx.doi.org/10.1021/jm960370r] [PMID: 9046333]
[http://dx.doi.org/10.1021/jm030796n] [PMID: 14584944]
[http://dx.doi.org/10.1371/journal.pone.0140878] [PMID: 26473363]
[http://dx.doi.org/10.1038/s41598-019-42816-4] [PMID: 31004122]
[http://dx.doi.org/10.1038/aps.2014.3] [PMID: 24727941]
[http://dx.doi.org/10.1016/j.colsurfb.2012.02.039] [PMID: 22445746]
[http://dx.doi.org/10.1021/ic802220w] [PMID: 19119867]
[http://dx.doi.org/10.1021/ml3000808] [PMID: 24900509]
[http://dx.doi.org/10.1002/jhet.3791]
[http://dx.doi.org/10.1039/C4NJ00936C]
[http://dx.doi.org/10.2478/acph-2014-0030] [PMID: 25296675]
[http://dx.doi.org/10.3797/scipharm.0905-07]
[http://dx.doi.org/10.3390/molecules17055870] [PMID: 22592090]
[http://dx.doi.org/10.3892/ijo.2019.4824] [PMID: 31268153]
[http://dx.doi.org/10.3332/ecancer.2017.781] [PMID: 29225688]
[http://dx.doi.org/10.4314/tjpr.v19i2.1]
[http://dx.doi.org/10.36108/pajols/1202.50.0240]
[http://dx.doi.org/10.1080/1062936X.2017.1419375] [PMID: 29347843]
[http://dx.doi.org/10.1001/jama.282.7.677] [PMID: 10517722]
[http://dx.doi.org/10.1080/13543776.2022.2012151] [PMID: 34846976]
[http://dx.doi.org/10.2174/1568026620666200903163921] [PMID: 32885754]
[http://dx.doi.org/10.3998/ark.5550190.0007.a25]
[http://dx.doi.org/10.1186/s43094-019-0016-7]
[http://dx.doi.org/10.1016/j.bmcl.2020.127576] [PMID: 32980514]
[http://dx.doi.org/10.4155/fmc-2017-0098] [PMID: 28869400]
[http://dx.doi.org/10.1002/slct.201702220]
[http://dx.doi.org/10.1016/j.bmcl.2017.02.031] [PMID: 28274627]
[http://dx.doi.org/10.1016/j.bmcl.2009.12.045] [PMID: 20056418]
[http://dx.doi.org/10.1016/j.biopha.2011.01.003] [PMID: 21602021]
[http://dx.doi.org/10.1016/j.ejmech.2022.114908] [PMID: 36435016]
[http://dx.doi.org/10.1016/j.ejmech.2015.06.032] [PMID: 26318054]
[http://dx.doi.org/10.1021/ml300134b] [PMID: 24900541]
[http://dx.doi.org/10.1056/NEJMoa0808427] [PMID: 19494215]